Balancing the risks and benefits of oxygen therapy in critically ill adults

GR Scott Budinger*, Gökhan M. Mutlu

*Corresponding author for this work

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Oxygen therapy is an integral part of the treatment of critically ill patients. Maintenance of adequate oxygen delivery to vital organs often requires the administration of supplemental oxygen, sometimes at high concentrations. Although oxygen therapy is lifesaving, it may be associated with deleterious effects when administered for prolonged periods at high concentrations. Here, we review the recent advances in our understanding of the molecular responses to hypoxia and high levels of oxygen and review the current guidelines for oxygen therapy in critically ill patients.

Original languageEnglish (US)
Pages (from-to)1151-1162
Number of pages12
JournalCHEST
Volume143
Issue number4
DOIs
StatePublished - Jan 1 2013

Fingerprint

Critical Illness
Oxygen
Therapeutics
Guidelines

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Budinger, GR Scott ; Mutlu, Gökhan M. / Balancing the risks and benefits of oxygen therapy in critically ill adults. In: CHEST. 2013 ; Vol. 143, No. 4. pp. 1151-1162.
@article{5f798ac5944342a8879b47893632884c,
title = "Balancing the risks and benefits of oxygen therapy in critically ill adults",
abstract = "Oxygen therapy is an integral part of the treatment of critically ill patients. Maintenance of adequate oxygen delivery to vital organs often requires the administration of supplemental oxygen, sometimes at high concentrations. Although oxygen therapy is lifesaving, it may be associated with deleterious effects when administered for prolonged periods at high concentrations. Here, we review the recent advances in our understanding of the molecular responses to hypoxia and high levels of oxygen and review the current guidelines for oxygen therapy in critically ill patients.",
author = "Budinger, {GR Scott} and Mutlu, {G{\"o}khan M.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1378/chest.12-1215",
language = "English (US)",
volume = "143",
pages = "1151--1162",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4",

}

Balancing the risks and benefits of oxygen therapy in critically ill adults. / Budinger, GR Scott; Mutlu, Gökhan M.

In: CHEST, Vol. 143, No. 4, 01.01.2013, p. 1151-1162.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Balancing the risks and benefits of oxygen therapy in critically ill adults

AU - Budinger, GR Scott

AU - Mutlu, Gökhan M.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Oxygen therapy is an integral part of the treatment of critically ill patients. Maintenance of adequate oxygen delivery to vital organs often requires the administration of supplemental oxygen, sometimes at high concentrations. Although oxygen therapy is lifesaving, it may be associated with deleterious effects when administered for prolonged periods at high concentrations. Here, we review the recent advances in our understanding of the molecular responses to hypoxia and high levels of oxygen and review the current guidelines for oxygen therapy in critically ill patients.

AB - Oxygen therapy is an integral part of the treatment of critically ill patients. Maintenance of adequate oxygen delivery to vital organs often requires the administration of supplemental oxygen, sometimes at high concentrations. Although oxygen therapy is lifesaving, it may be associated with deleterious effects when administered for prolonged periods at high concentrations. Here, we review the recent advances in our understanding of the molecular responses to hypoxia and high levels of oxygen and review the current guidelines for oxygen therapy in critically ill patients.

UR - http://www.scopus.com/inward/record.url?scp=84875977782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875977782&partnerID=8YFLogxK

U2 - 10.1378/chest.12-1215

DO - 10.1378/chest.12-1215

M3 - Article

C2 - 23546490

AN - SCOPUS:84875977782

VL - 143

SP - 1151

EP - 1162

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4

ER -